Loading…
A single dose sub-unit vaccine protects against pneumonic plague
In this study, the protection afforded against aerosolised Yersinia pestis by injection of a single dose of an alhydrogel-adsorbed sub-unit vaccine has been compared with that given by an existing killed whole cell vaccine licensed for human use. The sub-unit vaccine, prepared by admixing F1 antigen...
Saved in:
Published in: | Vaccine 2000-10, Vol.19 (4), p.566-571 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In this study, the protection afforded against aerosolised
Yersinia pestis by injection of a single dose of an alhydrogel-adsorbed sub-unit vaccine has been compared with that given by an existing killed whole cell vaccine licensed for human use. The sub-unit vaccine, prepared by admixing F1 antigen derived from a
Y. pestis cell culture supernatant with recombinant V antigen derived from an
E. coli cell lysate, fully protected an outbred strain of mouse against exposure to 10
6 CFU of virulent plague organisms (10
4 mouse lethal doses, MLD). In contrast, the whole cell vaccine provided only 16% protection against the same level of challenge. Furthermore, sub-unit vaccinees were able to clear the bacteria from their lungs post-challenge whereas bacteria were cultured from the lungs of a surviving KWC vaccinee post-challenge. In killed whole cell vaccinees, physiologically significant levels of IgG to F1 only were detectable and the levels of F1-specific IgG in serum and in broncho-alveolar washings were significantly lower (
p |
---|---|
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/S0264-410X(00)00159-6 |